As of 2025-07-12, the Intrinsic Value of Pharmagest Interactive SA (PHA.PA) is 48.37 EUR. This PHA.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 81.90 EUR, the upside of Pharmagest Interactive SA is -40.90%.
The range of the Intrinsic Value is 32.59 - 96.88 EUR
Based on its market price of 81.90 EUR and our intrinsic valuation, Pharmagest Interactive SA (PHA.PA) is overvalued by 40.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 32.59 - 96.88 | 48.37 | -40.9% |
| DCF (Growth 10y) | 37.53 - 104.12 | 54.01 | -34.1% |
| DCF (EBITDA 5y) | 40.64 - 50.63 | 47.16 | -42.4% |
| DCF (EBITDA 10y) | 43.97 - 58.44 | 52.24 | -36.2% |
| Fair Value | 22.04 - 22.04 | 22.04 | -73.08% |
| P/E | 44.77 - 125.98 | 76.71 | -6.3% |
| EV/EBITDA | 40.84 - 84.06 | 71.12 | -13.2% |
| EPV | 19.73 - 28.27 | 24.00 | -70.7% |
| DDM - Stable | 44.78 - 172.75 | 108.76 | 32.8% |
| DDM - Multi | 30.18 - 87.23 | 44.46 | -45.7% |
| Market Cap (mil) | 1,230.11 |
| Beta | 0.58 |
| Outstanding shares (mil) | 15.02 |
| Enterprise Value (mil) | 1,255.23 |
| Market risk premium | 5.23% |
| Cost of Equity | 7.60% |
| Cost of Debt | 5.00% |
| WACC | 7.37% |